| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |